Excerpt from: Formulation and Stabilization of Biotherapeutics MIT Professional Education: July 21-23, 2014. Mark Cornell Manning Provided courtesy of.

Slides:



Advertisements
Similar presentations
Insulin Ester Hydrolysis Megan Palmer Chee 450. Conversion of Insulin Ester Following enzymatic cleavage, must de-protect Thr B30 ester into Thr B30 carboxylic.
Advertisements

DNA Extraction Outline Purpose of DNA extraction
Stability data required by WHO-PQP Mercy Acquaye.
Planning Stability Studies During Product Development, Subcontracting Bob Seevers, Ph.D.
Determine impurity level in relevant batches1
Characterization of Al-Humic Complexation and Coagulation Mechanism Removal of natural organic matter (NOM) by coagulation using metal coagulants (aluminium.
Salting in and Salting out of proteins and Dialysis (Isolation Of Lactate Dehydrogenase Enzyme ) BCH 333 [practical]
Enzyme Assays on Chips. Introduction Enzyme assays are used for discovery and characterization of enzymes Identification of protein function instead of.
Emulsions and Microemulsions
DISPERSIONS - I. Classification by Size True Solutions (“Molecular Dispersions”)  (molecules, ions) in gas, liquid (solutions )  < 1 nm, diffuse easily.
THE USE OF DEUTERIUM OXIDE TO STABILIZE PHARMACEUTICALS AGAINST CHEMICAL DEGRADATION KHO KIAT NEE.
VINOD P. SHAH, PH.D. SENIOR RESEARCH SCIENTIST OFFICE OF PHARMACEUTICAL SCIENCE CENTER FOR DRUG EVALUATION AND RESEARCH FOOD AND DRUG ADMINISTRATION Pharmacy.
FDA Workshop July 2003 Protein Delivery from Mechanical Devices Challenges and Opportunities Bill Van Antwerp and Poonam Gulati The Protein Formulation.
 Lee, Stabilising Proteins by Spray Drying with Adjuvents, 'Particle 2006' Berlin STABILISING PROTEINS BY SPRAY DRYING.
Chemical Weathering. I. Introduction Chemical Weathering I. Introduction II. Process of Decomposition A. Overview: Decomposition alters minerals into.
Dispersed Systems FDSC Version. Goals Scales and Types of Structure in Food Surface Tension Curved Surfaces Surface Active Materials Charged Surfaces.
B. AmsdenCHEE 440 Stability The extent to which a product retains, within specified limits, and throughout its period of storage and use, the same properties.
CHEE Stability u the extent to which a product retains, within specified limits, and throughout its period of storage and use, the same properties.
Pharmaceutical Biotechnology PHT 426 “Formulation of Biotech Products (2)” Dr. Mohammad Alsenaidy Department of Pharmaceutics College of Pharmacy King.
Buffers of Biological & Clinical Significance Lecture 4 Lecturer: Amal Abu Mostafa Lecture 4 Lecturer: Amal Abu Mostafa 1 Clinical Analytical Chemistry.
 Lee, Spray Drying Proteins, Breckenridge, July 2004 Spray Drying of Proteins Geoffrey Lee  Spray drying (SD) of protein-containing.
8.10 Preparation and purification of colloids. 1)Low solubility 2)Low concentration 3)Stabilizing reagent Basic requirement:
Quality by Design Application of Pharmaceutical QbD for Enhancement of the Solubility and Dissolution of a Class II BCS Drug using Polymeric Surfactants.
Biochemistry February Lecture Analytical & Preparative Protein Chemistry II.
Water, Solutions, and Membranes Roles of water in body functions Characteristics of water Solutions: composition, concentration, and pH Role of membranes.
3. The chemistry of life 3.6 Enzymes. Enzymes: are globular proteins that work as catalysts – they speed up chemical reactions without being altered themselves.
CHAPTER 6 AN INTRODUCTION TO METABOLISM
CHAPTER 6 AN INTRODUCTION TO METABOLISM Copyright © 2002 Pearson Education, Inc., publishing as Benjamin Cummings Section B: Enzymes 1.Enzymes speed up.
Stability of Drug Preparations Chapter 12. I. Introduction A.Importance Stability is the guarantee of safety and effectiveness of any preparations B.Types.
Protein Characterization BIT 230. Methods Many of these methods were covered through this course Understand purpose!
Advisory Committee for Pharmaceutical Science Process Analytical Technology and Biotechnology Products Keith O. Webber, Ph.D. Office of Biotechnology Products.
1-7.The ICH Q8 “Minimal Approach” to Pharmaceutical Development
Pharmaceutical Biotechnology PHT 426 “Insulin” Dr. Mohammad Alsenaidy Department of Pharmaceutics College of Pharmacy King Saud University Office: AA 101.
20/03/2008 Dept. of Pharmaceutics 1. Use of BIOINFORMATICS in Pharmaciutics 2  Presented By  Shafnan Nazar  Hamid Nasir 
AGGREGATION OF THERAPEUTIC PROTEINS (W.Wang, C.J.Roberts, Chapters 3 and 4) AGGREGATION is a natural consequence of the response of a protein molecule.
Stabilizing Fluorochrome-Labeled Antibodies in Lyophilization with Disaccharide Excipients Meredith Pearcy 2005.
Aquatic Chemistry 367 Civil and Environmental Engineering Meeting time: MWF 11:00-11:50am Meeting room: Abbott Auditorium in Pancoe Pavillion Instructor:
Predicting Physical Stability in Q1A(R) Chi-wan Chen, Ph.D. Office of New Drug Chemistry Center for Drug Evaluation and Research Food and Drug Administration.
HELM AG Module 3 Christa Clasen Ankara, 6./7. April 2006.
Hein * Best * Pattison * Arena
CHEE 4401 Definitions drug - any substance that affects the structure or functioning of an organism pharmaceutics - the area of study concerned with the.
Satish Mallya January 20-22, |1 | 2-3. Pharmaceutical Development Satish Mallya Quality Workshop, Copenhagen May 18-21, 2014 May 18-21,2014.
Developing Real World Tests and Assays Using Gold Particles Arista Biologicals Inc.
Ameeta Parekh, Ph.D. CDER/OCPB CPSC Meeting November 17/18
Inorganic and Analytical Chemistry
SUSPENSIONS. SUSPENSIONS are micro heterogeneous dispersion systems consisting of solid medicinal substances in the suspended state, which are in the.
SUSPENSIONS. SUSPENSIONS are micro heterogeneous dispersion systems consisting from solid medicinal substances in the suspended state, which are in the.
LYOPHILIZATION TECHNIQUE: OVERVIEW
Impurities in Drugs author: srikanth N
Physical and chemical properties of proteins. Denaturation.
Definitive Screening Design—A Novel Statistical Tool to Leverage Information in Early Development Stages 1 Vishal C Nashine 27 OCTOBER 2015 AAPS-AM.
Goals of Preformulation
Chapter 1: The Nature of Analytical Chemistry
Water, Water Everywhere! Essential Questions: What are the properties of Water? What are Mixtures, Solutions and Suspensions? Why is water important for.
Compost pH. pH pH decreases as the [H+] increases pH range is 0-14 At 25C the pH of an acidic solution is less than 7.00 At 25C the pH of a basic solution.
Teaching Aids Service by KRRC Information Section.
Protein therapeutics.
REGULATORY REQUIREMENTS FOR PREFORMULATION STUDIES
Ulrich Hintermair, Staff Sheehan, Julie Thomsen
PEGYLATION: AN EFFECTIVE TOOL FOR BIOMASKING
8.6 Preparation and purification of colloids
WHO Technical Report Series, No. 953, 2009
CHAPTER 6 AN INTRODUCTION TO METABOLISM
Drug Delivery Systems Pharmaceutical technology Petra University.
Water, Water Everywhere!
Proteins.
CHAPTER 6 AN INTRODUCTION TO METABOLISM
FACTORS THAT AFFECT RATES OF REACTION
FIRDAUS HAFIZAH SOFIA AINIZA
2.4 - Proteins.
Presentation transcript:

Excerpt from: Formulation and Stabilization of Biotherapeutics MIT Professional Education: July 21-23, Mark Cornell Manning Provided courtesy of Somatek Inc Sorrento Valley Blvd. Suite G San Diego CA USA somatek.com

Formulation of Biotherapeutics: Introduction Mark Cornell Manning Legacy BioDesign, LLC July 21-23, 2014 M.I.T. © Legacy BioDesign LLC

Course Goals Appreciate the importance of formulation development in bringing a biopharmaceutical product to market Identify the primary aspects of stabilization of proteins against physical instability (e.g., aggregation) Learn about the primary mechanisms of chemical degradation Understand the mechanisms of aggregation and the impact on kinetic profiles

Course Goals Examine the analytical methods employed to detect and quantify the levels of soluble aggregates and subvisible particles in protein products Use these mechanistic insights to develop liquid, frozen, and lyophilized dosage forms of proteins in a rational and defensible manner Learn about some important nuances for stabilization of peptides, vaccines, ADCs, and PEGylated proteins

Role of Formulation in Drug Development To ensure optimal product ‘performance’ by the appropriate choice of (i) dosage form, (ii) excipients, (iii) process and (iv) packaging The latter are done in collaboration with other groups What is ‘performance’? Quality as measured by stability, solubility, potency, safety, etc.

Formulation Goals Develop a formulation strategy Obtain and meet the target profile Select dosage form Make excipient choices Assay development Employ accelerated stress testing/Select conditions IP constraints/goals Determine compatibility of formulation and container Ensure process and formulation are compatible

Three Primary Dosage Forms Frozen Solution Liquid Formulation Lyophilized Powder

Hallmark of a Good Formulation Simple (that’s why good formulations look easy) Manufacturing-friendly Safe (use appropriate excipients) Meets shelf-life objectives Satisfies target profile Meets time lines May involve ‘informed compromise’ Must be rational/defensible

Two Types of Protein Instability Deamidation Asp-isoAsp Interconversion (Asp Isomerization) Racemization/Epimerization Proteolysis Trp Hydrolysis Hinge Region Hydrolysis Beta-elimination Oxidation Denaturation Aggregation Precipitation Surface Adsorption CHEMICALPHYSICAL Disulfide Exchange DKP Formation Condensation Reactions pGlu Formation Manning et al., Pharm. Res. 2010, 27:

Differences of Proteins from Small Molecules 1 Proteins are multi-functional 2 Most proteins adopt a globular structure that is essential for activity 3 Molecular weight differences 4 Numerous chiral centers in proteins 5 Unique pH response for each protein 6 Proteins are immunogenic

Considerations for Liquid Formulations Increased desirability for marketing Chemical stability is harder to control Excipients may include excluded solutes, surfactants, buffers, chemical stabilizers, others Damage due to agitation is a potential issue for transport and handling Need to evaluate F/T stability Higher protein concentration formulations raise additional issues

Important Aspects of Physical Stability  Conformational Stability Is the 3-D structure maintained?  Colloidal Stability How strong are protein-protein interactions?  Interfacial Stability Does exposure to interfaces cause damage?

Considerations for Lyo Formulations Physical stability is better (less aggregation) Chemical stability is easier to control (no water) Excipients may include lyo protectants, buffers, bulking agents, sometimes others Room temperature stable product is possible No worry about agitation-induced damage during shipping Higher protein concentration formulations raise additional issues

Importance of Analytical Methods All formulation development is assay limited Structural tools are essential for proper development of protein formulations (but have limitations) HPLC is still the centerpiece of stability testing (RP, SEC, IEX) Different analytical methods are needed for liquid development vs. dried formulations Critical issue is knowing which method is needed for each purpose or need